Moclobemide - Depression
You are here : Home > Formulary Search > Moclobemide - Depression
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Blue
Formulations :
- Tablets
Formulary Status :
Associated Icons :
Restrictions / Comments :
Important
Initiation and stabilisation by specialist for a minimum of 6 months before transfer of prescribing to primary care.
Documentation
Shared Care
PAD Profile
ChemicalSubstance :
Moclobemide
Indication :
Depression
Group Name :
Keywords :
MAOIs, monoamine oxidase inhibitors, depressive illness, antidepressants, RIMA, reversible inhibitor of monamine oxidase
Brand Names Include :
Manerix
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1
Other Indications
Below are listed other indications that Moclobemide is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Depression.
Committee Recommendations (1)
The Surrey Heartland Integrated Care System Area Prescribing Committee have agreed a BLUE (with information sheet) traffic light status for:
· Phenelzine
· Isocarboxacid
· Moclobemide
· Tranylcypromine
Specialists will initiate and prescribe a minimum of 6 months or until the patient is stable, whichever is longer, prior to transfer of care